论文部分内容阅读
目的 :观察低分子肝素治疗急性脑梗死的疗效。方法 :将 4 0例随机分为两组 :不加低分子肝素组病人口服银杏叶提取物、尼莫地平、阿司匹林等药物治疗 :加低分子肝素组除上述药物外 ,皮下注射低分子肝素 0 2 5ml/次 ,每日 2次 ,连用 5天后改 1次 /天 ,再用 5天。结果 :两组在神经功能缺损评分及临床疗效比较中 ,加低分子肝素组的疗效明显优于不加低分子肝素组 ,有效、显效率达 90 %。结论 :低分子肝素是治疗急性脑梗死的安全有效的药物
Objective: To observe the effect of low molecular weight heparin on acute cerebral infarction. Methods: 40 cases were randomly divided into two groups: patients without low molecular weight heparin ginkgo leaf extract, nimodipine, aspirin and other drugs: plus low molecular weight heparin group in addition to the above drugs, subcutaneous injection of low molecular weight heparin 0 2 5ml / time, 2 times a day, once every 5 days to change 1 times / day, then 5 days. Results: In the two groups in neurological deficit score and clinical efficacy comparison, plus low molecular weight heparin group was significantly better than without low molecular weight heparin group, effective, markedly effective rate of 90%. Conclusion: Low molecular weight heparin is a safe and effective drug for the treatment of acute cerebral infarction